Literature DB >> 7877872

Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease.

A H Rowley1, S M Wolinsky, D A Relman, S P Sambol, J Sullivan, M Terai, S T Shulman.   

Abstract

The use of conventional methods to detect a possible infectious cause of Kawasaki disease (KD) has been unsuccessful. Using the polymerase chain reaction and DNA hybridization techniques, we have sought evidence that a known or new herpesvirus, parvovirus, or bacterial pathogen is related etiologically to KD. Peripheral blood DNA from acute KD patients was subjected to amplification and dot-blot hybridization to detect the presence of herpesvirus DNA, and acute KD peripheral blood and serum DNA were subjected to dot-blot hybridization for the presence of parvoviral DNA. All samples were negative for both herpesvirus and parvovirus DNA. In addition, we analyzed buffy-coat white blood cell DNA, synovial fluid DNA, and frozen autopsy and formalin-fixed, paraffin-embedded myocardial tissue DNA from KD patients for the presence of highly conserved bacterial 16S ribosomal RNA gene sequences with the polymerase chain reaction, and all were negative. These results argue against a direct pathogenic role for herpesviruses, parvoviruses, and bacteria in KD. This approach to the detection of highly conserved genomic sequences among broad groups of microorganisms can be adapted for the detection of other groups of microorganisms and may yet prove useful in the search for an etiologic agent of KD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7877872     DOI: 10.1203/00006450-199411000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  14 in total

Review 1.  Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates.

Authors:  D N Fredricks; D A Relman
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

2.  HSP60, HSP70 in the pathogenesis of Kawasaki disease: implication and action.

Authors:  W Lu; P Cheng; S Chen
Journal:  J Tongji Med Univ       Date:  1998

3.  Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.

Authors:  Pong Kian Chua; Marian E Melish; Qigui Yu; Richard Yanagihara; Kara S Yamamoto; Vivek R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

Review 4.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 5.  Kawasaki disease. The mystery continues.

Authors:  D J Bradley; M P Glodé
Journal:  West J Med       Date:  1998-01

Review 6.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

7.  Seasonality and temporal clustering of Kawasaki syndrome.

Authors:  Jane C Burns; Daniel R Cayan; Garrick Tong; Emelia V Bainto; Christena L Turner; Hiroko Shike; Tomisaku Kawasaki; Yosikazu Nakamura; Mayumi Yashiro; Hiroshi Yanagawa
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

Review 8.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

Review 9.  Molecular approaches to the identification of unculturable infectious agents.

Authors:  S J Gao; P S Moore
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

10.  Non-Typhoidal Salmonella and the Risk of Kawasaki Disease: A Nationwide Population-Based Cohort Study.

Authors:  Thomas Yen-Ting Chen; Mei-Chia Chou; Jung-Nien Lai; Lu-Ting Chiu; Renin Chang; Yao-Min Hung; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.